ABBV-3373
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABBV-3373, covering 2021-07-19 to 2021-07-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA) [Phase 2]